FUSILEV

Acrotech Biopharma Llc

Application Filed: 2008-03-07
Trademark Application Details
Trademark Logo FUSILEV

Mark For: FUSILEV® trademark registration is intended to cover the categories of pharmaceutical preparation for the treatment of folic deficiency, methotrexate rescue, impaired methotrexate elimination, inadvertent overdosage of folic acid antagonists, osteosarcoma, and colorectal indications. [all]

Status

2022-04-27 UTC
DEAD REGISTRATION Cancelled Invalidated
The trademark application was registered, but subsequently it was cancelled or invalidated and removed from the registry.


Research OneLook Acronym Finder
Serial Number77415998
Registration Number3667433
Mark Literal ElementsFUSILEV
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Affidavit TextSECT 15. SECT 8 (6-YR).
Current LocationTMEG LAW OFFICE 103 2020-03-18
Basis1(a)
Class StatusSECTION 8 - CANCEL
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseYes
Intent To UseNo
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameLouis C. Cullman
Attorney Docket Number1959396
Law Office AssignedL30
Employee NameSPARACINO, MARK V

Timeline

2008-03-07Application Filed
2008-08-05Published
2008-08-05Published for Opposition
2008-08-15Date of First Use
2008-08-15Date of Use In Commerce
2009-08-11Trademark Registered
2015-08-28Status: Live/Registered
2019-09-16Location: TMEG LAW OFFICE 103
2019-09-17Transaction Date
2020-03-18Cancelled
2020-03-18Location: TMEG LAW OFFICE 103
2020-03-18Status: Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this

Trademark Parties (Applicants & Owners)

Party: ACROTECH BIOPHARMA LLC
Address279 PRINCETON HIGHTSTOWN ROAD EAST WINDSOR, NEW JERSEY UNITED STATES 08520
Legal Entity TypeLimited Liability Company
Legal Entity StateDELAWARE

Documents

Application2008-03-07
Drawing2008-03-07
Offc Action Outgoing2008-05-13
XSearch Search Summary2008-05-13
Response to Office Action2008-06-23
Amendment and Mail Process Complete2008-06-25
TRAM Snapshot of App at Pub for Oppostn2008-07-02
Publication & Issue Review Complete2008-07-03
Notice of Publication2008-07-16
Notice of Allowance2008-10-28
Extension of Time to File SOU2009-04-28
ITU Extension Approval2009-05-16
ITU Unit Action2009-05-16
Specimen2009-06-29
Statement of Use2009-06-29
ITU Unit Action2009-07-01
Notice of Acceptance of Statement of Use2009-07-07
Publication & Issue Review Complete2009-07-07
TRAM Snapshot of App at Pub for Oppostn2009-07-07
Registration Certificate2009-08-11
Change of Address2013-02-20
Section 8 and 152015-07-29
Specimen2015-07-29
Notice of Acceptance Acknowledgement2015-08-28
Courtesy E-Reminder of Sec. 8/Sec. 92018-08-11
PR-Section 8 and 92019-08-01
Specimen2019-08-01
Offc Action Outgoing2019-09-16
Notice of Cancellation Sec. 8 Email2020-03-19

Attorney of Record

Louis C. Cullman
K&L GATES LLP
1 Park Plaza, 12th Floor
Irvine CA 92614

Good, Services, and Codes

(CANCELLED)
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparation for the treatment of folic deficiency, methotrexate rescue, impaired methotrexate elimination, inadvertent overdosage of folic acid antagonists, osteosarcoma, and colorectal indications. FIRST USE: 20080815. FIRST USE IN COMMERCE: 20080815

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceutical preparation for the treatment of folic deficiency, methotrexate rescue, impaired methotrexate elimination, inadvertent overdosage of folic acid antagonists, osteosarcoma, and colorectal indications

Trademark Filing History

DescriptionDateProceeding Number
NOTICE OF CANCELLATION SEC. 8 EMAILED2020-03-19
CANCELLED SEC. 8 (10-YR)2020-03-1870833
POST REGISTRATION ACTION MAILED - SEC. 8 & 92019-09-1670833
CASE ASSIGNED TO POST REGISTRATION PARALEGAL2019-09-1370833
TEAS SECTION 8 & 9 RECEIVED2019-08-01
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP2019-06-05
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED2018-08-11
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.2015-08-2866607
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED2015-08-28
CASE ASSIGNED TO POST REGISTRATION PARALEGAL2015-08-2866607
TEAS SECTION 8 & 15 RECEIVED2015-07-29
TEAS CHANGE OF CORRESPONDENCE RECEIVED2013-02-20
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY2012-10-03
REGISTERED-PRINCIPAL REGISTER2009-08-11
LAW OFFICE REGISTRATION REVIEW COMPLETED2009-07-0670138
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED2009-07-04
STATEMENT OF USE PROCESSING COMPLETE2009-06-3066230
USE AMENDMENT FILED2009-06-2966230
TEAS STATEMENT OF USE RECEIVED2009-06-29
SOU EXTENSION 1 GRANTED2009-05-1566230
CASE ASSIGNED TO INTENT TO USE PARALEGAL2009-05-1566230
TEAS EXTENSION RECEIVED2009-04-28
SOU EXTENSION 1 FILED2009-04-2866230
NOA MAILED - SOU REQUIRED FROM APPLICANT2008-10-28
PUBLISHED FOR OPPOSITION2008-08-05
NOTICE OF PUBLICATION2008-07-16
LAW OFFICE PUBLICATION REVIEW COMPLETED2008-07-0270138
ASSIGNED TO LIE2008-07-0170138
APPROVED FOR PUB - PRINCIPAL REGISTER2008-07-01
TEAS/EMAIL CORRESPONDENCE ENTERED2008-06-2488889
TEAS RESPONSE TO OFFICE ACTION RECEIVED2008-06-23
CORRESPONDENCE RECEIVED IN LAW OFFICE2008-06-2388889
NOTIFICATION OF NON-FINAL ACTION E-MAILED2008-05-136325
NON-FINAL ACTION WRITTEN2008-05-1374304
NON-FINAL ACTION E-MAILED2008-05-136325
ASSIGNED TO EXAMINER2008-05-1374304
NEW APPLICATION ENTERED IN TRAM2008-03-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed